Quest Diagnostics Incorporated (DGX)vsThermo Fisher Scientific Inc (TMO)
DGX
Quest Diagnostics Incorporated
$233.72
+0.76%
HEALTHCARE · Cap: $25.72B
TMO
Thermo Fisher Scientific Inc
$574.03
-1.62%
HEALTHCARE · Cap: $194.53B
Smart Verdict
WallStSmart Research — data-driven comparison
Thermo Fisher Scientific Inc generates 291% more annual revenue ($45.20B vs $11.56B). TMO leads profitability with a 15.1% profit margin vs 9.2%. TMO appears more attractively valued with a PEG of 1.73. DGX earns a higher WallStSmart Score of 60/100 (C).
DGX
Buy60
out of 100
Grade: C
TMO
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DGX.
Margin of Safety
-72.9%
Fair Value
$333.36
Current Price
$574.03
$240.67 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Large-cap with strong market position
Generating 1.7B in free cash flow
Areas to Watch
Expensive relative to growth rate
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DGX
Revenue growth of 10.2% demonstrates continued momentum.
Bull Case : TMO
The strongest argument for TMO centers on Market Cap, Free Cash Flow. Profitability is solid with margins at 15.1% and operating margin at 17.9%.
Bear Case : DGX
The primary concerns for DGX are PEG Ratio.
Bear Case : TMO
The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
DGX profiles as a value stock while TMO is a mature play — different risk/reward profiles.
TMO carries more volatility with a beta of 0.87 — expect wider price swings.
DGX is growing revenue faster at 10.2% — sustainability is the question.
TMO generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
DGX scores higher overall (60/100 vs 59/100) and 10.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Quest Diagnostics Incorporated
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Thermo Fisher Scientific Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?